Proactively manage your pharmacy inventory
Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
Find generic entry opportunities
Anticipate generic drug launch
|Title:||Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(t- rifluoromethoxy)[1,1'-biphenyl]-3-carboxamide|
|Abstract:||Salts of N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-- (trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide are prepared and characterized.|
|Inventor(s):||Bajwa; Joginder (Elmwood Park, NJ), de la Cruz; Marilyn (Matawan, NJ), Dodd; Stephanie Kay (Ayer, MA), Waykole; Liladhar Murlidhar (Succasunna, NJ), Wu; Raeann (Pine Brook, NJ)|
|Assignee:||Novartis AG (Basel, CH)|
1. A diphosphate salt of N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluor- omethoxy)[1,1'-biphenyl]-3-carboxamide.
2. A pharmaceutical composition comprising: (a) a therapeutically effective amount of a salt according to claim 1; and (b) at least one pharmaceutically acceptable carrier, diluent, vehicle or excipient.